• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Use of Buprenorphine/Naloxone in an Adult with Cystic Fibrosis.丁丙诺啡/纳洛酮在一名成年囊性纤维化患者中的应用。
Can J Hosp Pharm. 2025 Jun 11;78(2):e3700. doi: 10.4212/cjhp.3700. eCollection 2025.
2
Comparative Effectiveness of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use Among People with Opioid Use Disorder in Canada.丁丙诺啡/纳洛酮与美沙酮对加拿大阿片类物质使用障碍患者甲基苯丙胺/苯丙胺使用情况的比较疗效
Subst Use Addctn J. 2025 Jul;46(3):518-530. doi: 10.1177/29767342241298044. Epub 2024 Nov 29.
3
Post-Overdose Extended-Release Buprenorphine Initiation Facilitated by a Partnership Between Emergency Medical Services and an Outpatient Substance Use Disorder Observation Unit.急诊医疗服务与门诊药物使用障碍观察单位合作，促进阿片类药物过量后长效丁丙诺啡的起始治疗。
Subst Use Addctn J. 2024 Oct;45(4):771-776. doi: 10.1177/29767342241249386. Epub 2024 May 12.
4
Gestational buprenorphine-naloxone exposure and fetal neurobehavior.妊娠期间使用丁丙诺啡-纳洛酮与胎儿神经行为。
Neurotoxicol Teratol. 2024 Jul-Aug;104:107368. doi: 10.1016/j.ntt.2024.107368. Epub 2024 Jun 19.
5
Retention in Opioid Agonist Therapy Among First Nations People.原住民接受阿片类激动剂治疗的留存情况。
JAMA Netw Open. 2025 Jun 2;8(6):e2518452. doi: 10.1001/jamanetworkopen.2025.18452.
6
Duration of Methadone and Buprenorphine-Naloxone Treatment.美沙酮及丁丙诺啡-纳洛酮治疗的持续时间。
JAMA Netw Open. 2025 Jul 1;8(7):e2518389. doi: 10.1001/jamanetworkopen.2025.18389.
7
Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data.美沙酮与丁丙诺啡治疗阿片类物质使用障碍的有效性：前瞻性队列研究数据的二次分析
BMJ Open. 2025 Jun 17;15(6):e095645. doi: 10.1136/bmjopen-2024-095645.
8
Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning.丁丙诺啡 - 纳洛酮治疗持续率的可预测性：一项结合电子健康记录和机器学习的多中心分析
Addiction. 2024 Oct;119(10):1792-1802. doi: 10.1111/add.16587. Epub 2024 Jun 24.
9
Incidence of buprenorphine-precipitated opioid withdrawal in adults with opioid use disorder: A systematic review.阿片类药物使用障碍成人中丁丙诺啡诱发的阿片类药物戒断发生率：一项系统评价。
Addiction. 2025 Jan;120(1):7-20. doi: 10.1111/add.16646. Epub 2024 Sep 25.
10
Randomized, placebo-controlled trial of injectable extended-release naltrexone and injectable extended-release buprenorphine for cocaine use disorder (CURB-2): Study rationale and design.注射用长效纳曲酮与注射用长效丁丙诺啡治疗可卡因使用障碍的随机、安慰剂对照试验（CURB-2）：研究原理与设计
Contemp Clin Trials. 2025 Jul;154:107954. doi: 10.1016/j.cct.2025.107954. Epub 2025 May 11.

本文引用的文献

1
Alcohol and opiate misuse in adults with cystic fibrosis.成人囊性纤维化患者中的酒精和阿片类药物滥用。
Pediatr Pulmonol. 2023 Sep;58(9):2535-2542. doi: 10.1002/ppul.26541. Epub 2023 Jun 9.
2
Satisfaction and effectiveness of opioid pain management among adults with cystic fibrosis: A mixed methods study.成人囊性纤维化患者阿片类药物疼痛管理的满意度和效果：一项混合方法研究。
J Cyst Fibros. 2022 Jan;21(1):e15-e22. doi: 10.1016/j.jcf.2021.06.007. Epub 2021 Jul 10.
3
Benefit-Risk Analysis of Buprenorphine for Pain Management.丁丙诺啡用于疼痛管理的获益-风险分析。
J Pain Res. 2021 May 24;14:1359-1369. doi: 10.2147/JPR.S305146. eCollection 2021.
4
Pain and its clinical associations in individuals with cystic fibrosis: A systematic review.囊性纤维化患者的疼痛及其临床关联：系统评价。
Chron Respir Dis. 2016 May;13(2):102-17. doi: 10.1177/1479972316631135. Epub 2016 Feb 12.
5
Pain in CF: review of the literature.CF 相关疼痛：文献综述。
J Cyst Fibros. 2013 Sep;12(5):423-30. doi: 10.1016/j.jcf.2013.04.001. Epub 2013 Apr 28.
6
Buprenorphine in postoperative pain management.丁丙诺啡用于术后疼痛管理。
Anesthesiol Clin. 2010 Dec;28(4):601-9. doi: 10.1016/j.anclin.2010.08.015.

Use of Buprenorphine/Naloxone in an Adult with Cystic Fibrosis.

作者信息

Mihic Tamara, Fairbairn Nadia, Nolan Seonaid, Dagenais Renée, Quon Bradley S, Socias M Eugenia

机构信息

BSc(Pharm), ACRP, PharmD, is with St Paul's Hospital, the British Columbia Centre on Substance Use, and the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.

MD, FRCPC, MHSc, is with St Paul's Hospital, the British Columbia Centre on Substance Use, and the Department of Medicine, The University of British Columbia, Vancouver, British Columbia.

出版信息

Can J Hosp Pharm. 2025 Jun 11;78(2):e3700. doi: 10.4212/cjhp.3700. eCollection 2025.

DOI:10.4212/cjhp.3700
PMID:40503554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12119097/
Abstract
摘要